GLP-1 agonist drugs like Ozempic do not increase thyroid cancer risk
New research from Sweden has found that GLP-1 agonist drugs used to treat diabetes and obesity are unlikely to increase thyroid cancer risk, as some previous studies had suggested.
About The Author
Discover more from MEK Enterprises Blog - Breaking News, SEO, Information, and Making Money Online!
Subscribe to get the latest posts sent to your email.